Odyssey Therapeutics Statistics
Total Valuation
ODTX has a market cap or net worth of $1.02 billion. The enterprise value is $610.02 million.
| Market Cap | 1.02B |
| Enterprise Value | 610.02M |
Important Dates
The next estimated earnings date is Thursday, September 17, 2026, after market close.
| Earnings Date | Sep 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ODTX has 47.92 million shares outstanding. The number of shares has increased by 1,383.37% in one year.
| Current Share Class | 47.92M |
| Shares Outstanding | 47.92M |
| Shares Change (YoY) | +1,383.37% |
| Shares Change (QoQ) | +435.34% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | 13.36% |
| Float | 23.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10,333.93 |
| Forward PS | n/a |
| PB Ratio | 2.31 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6,210.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.36, with a Debt / Equity ratio of 0.06.
| Current Ratio | 11.36 |
| Quick Ratio | 10.98 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,983.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -37.60% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $990 |
| Profits Per Employee | -$1.60M |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 18.09 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 61.02 |
| Average Volume (20 Days) | 187,390 |
Short Selling Information
The latest short interest is 1.99 million, so 4.16% of the outstanding shares have been sold short.
| Short Interest | 1.99M |
| Short Previous Month | 1.80M |
| Short % of Shares Out | 4.16% |
| Short % of Float | 8.33% |
| Short Ratio (days to cover) | 5.05 |
Income Statement
In the last 12 months, ODTX had revenue of $99,000 and -$160.03 million in losses. Loss per share was -$14.05.
| Revenue | 99,000 |
| Gross Profit | -120.62M |
| Operating Income | -154.83M |
| Pretax Income | -161.07M |
| Net Income | -160.03M |
| EBITDA | -166.72M |
| EBIT | -171.28M |
| Loss Per Share | -$14.05 |
Balance Sheet
The company has $310.58 million in cash and $24.83 million in debt, with a net cash position of $408.24 million or $8.52 per share.
| Cash & Cash Equivalents | 310.58M |
| Total Debt | 24.83M |
| Net Cash | 408.24M |
| Net Cash Per Share | $8.52 |
| Equity (Book Value) | 421.22M |
| Book Value Per Share | 8.80 |
| Working Capital | 293.17M |
Cash Flow
In the last 12 months, operating cash flow was -$132.13 million and capital expenditures -$610,000, giving a free cash flow of -$132.74 million.
| Operating Cash Flow | -132.13M |
| Capital Expenditures | -610,000 |
| Depreciation & Amortization | 4.56M |
| Net Borrowing | n/a |
| Free Cash Flow | -132.74M |
| FCF Per Share | -$2.77 |
Margins
| Gross Margin | n/a |
| Operating Margin | -156,392.93% |
| Pretax Margin | -162,695.96% |
| Profit Margin | n/a |
| EBITDA Margin | -168,403.03% |
| EBIT Margin | -173,008.08% |
| FCF Margin | n/a |
Dividends & Yields
ODTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,383.37% |
| Shareholder Yield | -1,383.37% |
| Earnings Yield | -15.64% |
| FCF Yield | -12.97% |
Analyst Forecast
The average price target for ODTX is $33.00, which is 55.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.00 |
| Price Target Difference | 55.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ODTX has an Altman Z-Score of 5.7 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.7 |
| Piotroski F-Score | 2 |